These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 17339605

  • 1. IFI16 in human prostate cancer.
    Alimirah F, Chen J, Davis FJ, Choubey D.
    Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605
    [Abstract] [Full Text] [Related]

  • 2. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P, Schweyer S, Hemmerlein B, Wuttke W, Seseke F, Ringert RH.
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [Abstract] [Full Text] [Related]

  • 3. Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 protein.
    Alimirah F, Chen J, Xin H, Choubey D.
    FEBS Lett; 2006 Mar 06; 580(6):1659-64. PubMed ID: 16494870
    [Abstract] [Full Text] [Related]

  • 4. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
    Frønsdal K, Saatcioglu F.
    Prostate; 2005 Feb 15; 62(3):299-306. PubMed ID: 15389787
    [Abstract] [Full Text] [Related]

  • 5. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H, Lee YJ, Kim TH, Lee J, Yoon S, Choi WS, Myung CS, Kim HS.
    Int J Mol Med; 2008 Nov 15; 22(5):605-11. PubMed ID: 18949380
    [Abstract] [Full Text] [Related]

  • 6. Expression of an IFN-inducible cellular senescence gene, IFI16, is up-regulated by p53.
    Song LL, Alimirah F, Panchanathan R, Xin H, Choubey D.
    Mol Cancer Res; 2008 Nov 15; 6(11):1732-41. PubMed ID: 18974396
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 8. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S, Venkatasubbarao K, Li S, Freeman JW.
    Cancer Res; 2003 May 15; 63(10):2624-30. PubMed ID: 12750289
    [Abstract] [Full Text] [Related]

  • 9. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K, Pašková L, Matiješčuková N, Kolář Z.
    Cancer Biomark; 2010 May 15; 7(2):79-90. PubMed ID: 21178266
    [Abstract] [Full Text] [Related]

  • 10. Androgen receptor level controlled by a suppressor complex lost in an androgen-independent prostate cancer cell line.
    Wang LG, Ossowski L, Ferrari AC.
    Oncogene; 2004 Jul 01; 23(30):5175-84. PubMed ID: 15156193
    [Abstract] [Full Text] [Related]

  • 11. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
    Xin H, Curry J, Johnstone RW, Nickoloff BJ, Choubey D.
    Oncogene; 2003 Jul 31; 22(31):4831-40. PubMed ID: 12894224
    [Abstract] [Full Text] [Related]

  • 12. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells.
    Huang H, Reed CP, Zhang JS, Shridhar V, Wang L, Smith DI.
    Cancer Res; 1999 Jun 15; 59(12):2981-8. PubMed ID: 10383164
    [Abstract] [Full Text] [Related]

  • 13. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A, Biancolella M, Amati F, Gravina P, Miano R, Chillemi G, Farcomeni A, Bueno S, Vespasiani G, Desideri A, Federici G, Novelli G, Bernardini S.
    Drug Metab Dispos; 2007 Jun 15; 35(6):968-72. PubMed ID: 17371798
    [Abstract] [Full Text] [Related]

  • 14. Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells.
    Gray SG, Ekström TJ.
    Biochem Biophys Res Commun; 1998 Apr 17; 245(2):423-7. PubMed ID: 9571167
    [Abstract] [Full Text] [Related]

  • 15. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH.
    Int J Oncol; 2005 Aug 17; 27(2):473-9. PubMed ID: 16010430
    [Abstract] [Full Text] [Related]

  • 16. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells.
    Noh EJ, Jang ER, Jeong G, Lee YM, Min CK, Lee JS.
    Cancer Res; 2005 Dec 15; 65(24):11400-10. PubMed ID: 16357148
    [Abstract] [Full Text] [Related]

  • 17. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
    Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C.
    Cancer Res; 2002 Feb 01; 62(3):721-33. PubMed ID: 11830526
    [Abstract] [Full Text] [Related]

  • 18. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U, Renkawitz R, Baniahmad A.
    Anticancer Res; 2000 Feb 01; 20(2A):1017-22. PubMed ID: 10810390
    [Abstract] [Full Text] [Related]

  • 19. Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes.
    Mogal A, Abdulkadir SA.
    Mol Cell Probes; 2006 Apr 01; 20(2):81-6. PubMed ID: 16326072
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition.
    Kitamura H, Torigoe T, Asanuma H, Honma I, Sato N, Tsukamoto T.
    J Urol; 2007 Aug 01; 178(2):692-6. PubMed ID: 17574613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.